Published in Int J Immunogenet on August 01, 2006
Gene polymorphisms in chronic periodontitis. Int J Dent (2010) 1.08
Recognition of facial emotion in nine individuals with bilateral amygdala damage. Neuropsychologia (1999) 2.42
Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest (2001) 2.35
Effectiveness of 4 pulpotomy techniques--randomized controlled trial. J Dent Res (2005) 1.90
Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol (2001) 1.84
Laparoscopic-assisted resection of giant sigmoid lipoma under colonoscopic guidance. Surg Endosc (2002) 1.66
Accuracy of electronic apex locators in comparison to actual length--an in vivo study. J Dent (2005) 1.60
Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (1999) 1.60
Characterization of antigens from the human exocrine pancreatic tissue (Pag) relevant as target antigens for autoantibodies in Crohn's disease. Eur J Clin Invest (1999) 1.44
[Megaloblastic anemia due to inadequate nutrition]. Dtsch Med Wochenschr (1997) 1.39
Cotransport of H+, lactate and H2O by membrane proteins in retinal pigment epithelium of bullfrog. J Physiol (1996) 1.33
Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Gut (2005) 1.30
A polymorphism in the CD14 gene is associated with Crohn disease. Scand J Gastroenterol (2002) 1.28
Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease. Clin Exp Immunol (2004) 1.23
The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology (2002) 1.20
Water transport in the brain: role of cotransporters. Neuroscience (2004) 1.12
Regorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: results of a multicenter, phase Ib study. Ann Oncol (2013) 1.06
MICA, MICB and C1_4_1 polymorphism in Crohn's disease and ulcerative colitis. Tissue Antigens (2001) 1.05
Hepatic gene expression patterns in thyroid hormone-treated hypothyroid rats. J Mol Endocrinol (2003) 1.03
A 3' UTR transition within DEFB1 is associated with chronic and aggressive periodontitis. Genes Immun (2009) 1.03
Anti-inflammatory properties of unfractioned heparin in patients with highly active ulcerative colitis: a pilot study. Am J Gastroenterol (1997) 1.02
Polymorphisms of the ICAM-1 gene are associated with inflammatory bowel disease, regardless of the p-ANCA status. Clin Immunol (2001) 1.00
Human retinal pigment epithelial cell-induced apoptosis in activated T cells. Invest Ophthalmol Vis Sci (1998) 1.00
Interaction of polymorphisms in the CARD15 and CD14 genes in patients with Crohn disease. Scand J Gastroenterol (2003) 0.94
The role of the selenoprotein S (SELS) gene -105G>A promoter polymorphism in inflammatory bowel disease and regulation of SELS gene expression in intestinal inflammation. Tissue Antigens (2007) 0.92
Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: increased prevalence of ASCA and pANCA. Digestion (2004) 0.92
Candidate genes colocalized to linkage regions in inflammatory bowel disease. Digestion (2002) 0.91
Microgel assessment of nucleic acid integrity and labeling quality in microarray experiments. Biotechniques (2002) 0.91
The course of headache in idiopathic intracranial hypertension: a 12-month prospective follow-up study. Eur J Neurol (2014) 0.90
Noninvasive (13)C-octanoic acid breath test shows delayed gastric emptying in patients with amyotrophic lateral sclerosis. Digestion (2000) 0.88
Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis. Gut (1997) 0.88
Klippel-Trenaunay syndrome with involvement of coecum and rectum: a rare cause of lower gastrointestinal bleeding. Eur J Med Res (2004) 0.88
Interleukin-4 and interleukin-4 receptor gene polymorphisms in inflammatory bowel diseases. Genes Immun (2001) 0.88
The IL-10 gene is not involved in the predisposition to inflammatory bowel disease. Electrophoresis (2000) 0.87
The polymorphism at position -174 of the IL-6 gene is not associated with inflammatory bowel disease. Eur J Gastroenterol Hepatol (2001) 0.86
Multiplex detection of hotspot mutations by rolling circle-enabled universal microarrays. Lab Invest (2001) 0.86
The Delta 32 mutation of the chemokine-receptor 5 gene neither is correlated with chronic hepatitis C nor does it predict response to therapy with interferon-alpha and ribavirin. Clin Immunol (2003) 0.86
Bactericidal effects of 2.94 microns Er:YAG-laser radiation in dental root canals. J Endod (1999) 0.86
Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohorts. J Med Genet (2007) 0.85
Malaysian and Thai smokers' beliefs about the harmfulness of 'light' and menthol cigarettes. Tob Control (2010) 0.85
In situ detection of messenger RNA using digoxigenin-labeled oligonucleotides and rolling circle amplification. Exp Mol Pathol (2001) 0.85
The -295T-to-C promoter polymorphism of the IL-16 gene is associated with Crohn's disease. Clin Immunol (2003) 0.83
Adoptive transfer of genetic susceptibility to Crohn's disease. Gut (2004) 0.83
Dual-probe 24-hour ambulatory pH monitoring for diagnosis of laryngopharyngeal reflux. J Laryngol Otol (2004) 0.82
Response to combination therapy with interferon alfa-2a and ribavirin in chronic hepatitis C according to a TNF-alpha promoter polymorphism. Digestion (2003) 0.80
The leukocyte count predicts the efficacy of treatment with azathioprine in inflammatory bowel disease. Eur J Med Res (2005) 0.80
A polymorphism in the IL11 gene is associated with ulcerative colitis. Genes Immun (2002) 0.79
Association between the promoter polymorphism T/C at position -159 of the CD14 gene and anti-inflammatory therapy in patients with inflammatory bowel disease. Eur J Med Res (2005) 0.79
Immunohistochemical assessment of p170 provides prognostic information in endometrial carcinoma. Histopathology (1999) 0.79
Search for mumps virus genome in intestinal biopsy specimens of patients with IBD. Gastroenterology (1999) 0.79
The G2964A polymorphism of the STAT6 gene in inflammatory bowel disease. Dig Liver Dis (2004) 0.79
K-ras mutations in sera of patients with colorectal neoplasias and long-standing inflammatory bowel disease. Scand J Gastroenterol (2002) 0.79
Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C. Aliment Pharmacol Ther (2009) 0.79
Leukemic dermal infiltrates as a complication of central venous catheter placement. Cancer (1988) 0.78
Anti-saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their first-degree relatives: potential clinical value. Digestion (2002) 0.78
Delta 32 mutation of the chemokine-receptor 5 gene in inflammatory bowel disease. Clin Immunol (2001) 0.77
Methotrexate in ulcerative colitis. Aliment Pharmacol Ther (2003) 0.77
Complete regression of advanced HCC with long acting octreotide. Gut (2003) 0.77
No significant association between mutations in exons 6 and 8 of the autoimmune regulator (AIRE) gene and inflammatory bowel disease. Eur J Immunogenet (2004) 0.77
Serum p53 antibodies in patients with chronic inflammatory bowel disease. Gut (1998) 0.77
Comparison of inflammatory bowel disease at younger and older age. Eur J Med Res (2004) 0.77
Accuracy of 13C-urea breath test in clinical use for diagnosis of Helicobacter pylori infection. Z Gastroenterol (2000) 0.77
Prevalence of the -295 T-to-C promoter polymorphism of the interleukin (IL)-16 gene in periodontitis. Clin Exp Immunol (2005) 0.77
Serum antibodies in first-degree relatives of patients with IBD: a marker of disease susceptibility? A follow-up pilot-study after 7 years. Digestion (2005) 0.77
Increased plasma concentration of surfactant protein D in chronic periodontitis independent of SFTPD genotype: potential role as a biomarker. Tissue Antigens (2008) 0.76
Inflammatory bowel disease: no association between allele combinations of the interleukin (IL) I beta and IL-I receptor antagonist gene polymorphisms. Eur J Clin Invest (1998) 0.76
MICA*055: a new allele with eight GCT repeats in the exon 5 microsatellite. Tissue Antigens (2008) 0.76
Medical approaches and future options in chronic active ulcerative colitis. Int J Colorectal Dis (2004) 0.76
Heparin therapy for ulcerative colitis. Gastroenterology (2001) 0.75
[What is Crohn's disease?]. Internist (Berl) (2007) 0.75
[Comment on the contribution by R. Saekel: Paradigm change in dental care]. Gesundheitswesen (1997) 0.75
[From fecal occult blood testing to Genoccult?]. Z Gastroenterol (2003) 0.75
Pancreatic autoantibodies in Crohn's disease: a feasible diagnostic tool? Eur J Gastroenterol Hepatol (2005) 0.75
Factor V Leiden mutation in patients with inflammatory bowel disease. Gastroenterology (1999) 0.75
Clozapine and sudden death. Lancet (2000) 0.75
K-ras and p53 mutations in colonic lavage fluid of patients with colorectal neoplasias. Digestion (2001) 0.75
Baccalaureate education and the professional nurse for the Cabinet on Education and Professional Practice. Prairie Rose (1990) 0.75
[Multiple muscle abscesses in a Tibetan woman]. Internist (Berl) (2000) 0.75
[Chronic diarrhea after a journey to Sri Lanka]. Z Gastroenterol (2002) 0.75
[Indirect detection of genetic mutations in colon cancers]. Z Gastroenterol (1999) 0.75
[26-year-old female patient with elevated liver enzymes]. Z Gastroenterol (2002) 0.75
Closure of an enterocutaneous fistula by high dose intravenous immune globuline therapy in a patient with X-linked agammaglobulinemia. Am J Gastroenterol (2001) 0.75
[The Augsburg cooperation model for promoting dental health in childhood]. Gesundheitswesen (2001) 0.75
Effects of lithium on vigilance, psychomotoric performance and mood. Pharmakopsychiatr Neuropsychopharmakol (1979) 0.75
[Role of zinc in treatment of acute diarrhea]. Z Gastroenterol (1996) 0.75
Systemic levels of soluble CD44 variant 6 (sCD44v6) in chronic inflammatory bowel disease. Am J Gastroenterol (1996) 0.75
[Lithium: EEG, performance and mood under subchronic therapy (author's transl)]. Arzneimittelforschung (1978) 0.75